Two Sigma Securities’s Universe Pharmaceuticals Inc UPC Stock Holding History

Two Sigma Securities’s Portfolio UPC Stock Details UPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-151	Closed	-$22.1K	–	3230
2024 Q3	$22.1K	Buy	+151	New	+$257K	﹤0.01%	2482
2023 Q3	–	Sell	-5	Closed	-$6.65K	–	3514
2023 Q2	$6.65K	Buy	+5	New	+$10.8K	﹤0.01%	2643
2022 Q3	–	Sell	-5	Closed	-$10K	–	3126
2022 Q2	$10K	Buy	+5	New	+$19.1K	﹤0.01%	2056

Other funds holding UPC

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's UPC Position: Q4 2024 in Review

Two Sigma Securities sold out of Universe Pharmaceuticals Inc (UPC) in Q4 2024, closing a stake of 151 shares — an estimated $22.1K sold.

Two Sigma Securities first reported a position in UPC in Q2 2022 and held it in 3 quarters. The position peaked at $22.1K in Q3 2024. 3 funds tracked by Wall St. Rank hold UPC as of Q4 2024.

Two Sigma Securities reported no remaining Universe Pharmaceuticals Inc position as of Q4 2024 after selling out during the quarter.
Two Sigma Securities sold 151 Universe Pharmaceuticals Inc shares in Q4 2024, an estimated $22.1K.
Two Sigma Securities first reported a position in Universe Pharmaceuticals Inc in Q2 2022 and held it in 3 quarters.
Two Sigma Securities's Universe Pharmaceuticals Inc position peaked at $22.1K in Q3 2024.
3 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.